Literature DB >> 33317582

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score.

Jana Schaule1,2, Stephanie G C Kroeze3, Oliver Blanck4, Susanne Stera5, Klaus H Kahl6, Falk Roeder7, Stephanie E Combs8,9,10, David Kaul11, An Claes12, Markus M Schymalla13, Sonja Adebahr14,15,16, Franziska Eckert17, Fabian Lohaus16,18,19, Nasrin Abbasi-Senger20, Guido Henke21, Marcella Szuecs22, Michael Geier23, Nora Sundahl24, Daniel Buergy25, Reinhard Dummer26, Matthias Guckenberger3.   

Abstract

Entities:  

Year:  2020        PMID： 33317582      PMCID： PMC7734768          DOI： 10.1186/s13014-020-01708-y

Source DB:  PubMed          Journal:  Radiat Oncol        ISSN： 1748-717X            Impact factor:   3.481


× No keyword cloud information.
  1 in total

1.  Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score.

Authors:  Jana Schaule; Stephanie G C Kroeze; Oliver Blanck; Susanne Stera; Klaus H Kahl; Falk Roeder; Stephanie E Combs; David Kaul; An Claes; Markus M Schymalla; Sonja Adebahr; Franziska Eckert; Fabian Lohaus; Nasrin Abbasi-Senger; Guido Henke; Marcella Szuecs; Michael Geier; Nora Sundahl; Daniel Buergy; Reinhard Dummer; Matthias Guckenberger
Journal:  Radiat Oncol       Date:  2020-06-01       Impact factor: 3.481
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.